CA2243275A1 - Synthetic il-10 analogues - Google Patents
Synthetic il-10 analogues Download PDFInfo
- Publication number
- CA2243275A1 CA2243275A1 CA002243275A CA2243275A CA2243275A1 CA 2243275 A1 CA2243275 A1 CA 2243275A1 CA 002243275 A CA002243275 A CA 002243275A CA 2243275 A CA2243275 A CA 2243275A CA 2243275 A1 CA2243275 A1 CA 2243275A1
- Authority
- CA
- Canada
- Prior art keywords
- human
- production
- peptide
- amino acid
- substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract 35
- 239000000126 substance Substances 0.000 claims abstract 21
- 238000004519 manufacturing process Methods 0.000 claims abstract 18
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract 17
- 229920001184 polypeptide Polymers 0.000 claims abstract 16
- 125000000539 amino acid group Chemical group 0.000 claims abstract 14
- 150000001413 amino acids Chemical class 0.000 claims abstract 10
- 206010033645 Pancreatitis Diseases 0.000 claims abstract 7
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract 7
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract 7
- 239000000816 peptidomimetic Substances 0.000 claims abstract 6
- 238000011321 prophylaxis Methods 0.000 claims abstract 6
- 238000011282 treatment Methods 0.000 claims abstract 6
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract 5
- 238000002360 preparation method Methods 0.000 claims abstract 4
- 208000009608 Papillomavirus Infections Diseases 0.000 claims abstract 2
- 208000036142 Viral infection Diseases 0.000 claims abstract 2
- 230000009467 reduction Effects 0.000 claims abstract 2
- 230000009385 viral infection Effects 0.000 claims abstract 2
- 210000001616 monocyte Anatomy 0.000 claims 20
- 230000021995 interleukin-8 production Effects 0.000 claims 15
- 102100021943 C-C motif chemokine 2 Human genes 0.000 claims 10
- 210000001744 T-lymphocyte Anatomy 0.000 claims 10
- 230000035605 chemotaxis Effects 0.000 claims 10
- 230000005764 inhibitory process Effects 0.000 claims 10
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 claims 9
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 claims 5
- 101710155857 C-C motif chemokine 2 Proteins 0.000 claims 5
- 210000001266 CD8-positive T-lymphocyte Anatomy 0.000 claims 5
- 101000897480 Homo sapiens C-C motif chemokine 2 Proteins 0.000 claims 5
- 101100005713 Homo sapiens CD4 gene Proteins 0.000 claims 5
- 108010002352 Interleukin-1 Proteins 0.000 claims 5
- 102000000589 Interleukin-1 Human genes 0.000 claims 5
- 102000019223 Interleukin-1 receptor Human genes 0.000 claims 5
- 108050006617 Interleukin-1 receptor Proteins 0.000 claims 5
- 108090000978 Interleukin-4 Proteins 0.000 claims 5
- 241000283973 Oryctolagus cuniculus Species 0.000 claims 5
- 206010033647 Pancreatitis acute Diseases 0.000 claims 5
- 201000003229 acute pancreatitis Diseases 0.000 claims 5
- 230000003042 antagnostic effect Effects 0.000 claims 5
- 239000003613 bile acid Substances 0.000 claims 5
- 238000006243 chemical reaction Methods 0.000 claims 5
- 230000003399 chemotactic effect Effects 0.000 claims 5
- 238000000338 in vitro Methods 0.000 claims 5
- 210000000265 leukocyte Anatomy 0.000 claims 5
- 210000004072 lung Anatomy 0.000 claims 5
- 210000004698 lymphocyte Anatomy 0.000 claims 5
- 230000005012 migration Effects 0.000 claims 5
- 238000013508 migration Methods 0.000 claims 5
- 210000000440 neutrophil Anatomy 0.000 claims 5
- 102000004169 proteins and genes Human genes 0.000 claims 5
- 108090000623 proteins and genes Proteins 0.000 claims 5
- 238000011555 rabbit model Methods 0.000 claims 5
- 230000002269 spontaneous effect Effects 0.000 claims 5
- 108090001007 Interleukin-8 Proteins 0.000 claims 4
- 230000008595 infiltration Effects 0.000 claims 4
- 238000001764 infiltration Methods 0.000 claims 4
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 125000001433 C-terminal amino-acid group Chemical group 0.000 claims 1
- 230000002862 amidating effect Effects 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 230000008878 coupling Effects 0.000 claims 1
- 238000010168 coupling process Methods 0.000 claims 1
- 238000005859 coupling reaction Methods 0.000 claims 1
- 238000010647 peptide synthesis reaction Methods 0.000 claims 1
- 210000005259 peripheral blood Anatomy 0.000 claims 1
- 239000011886 peripheral blood Substances 0.000 claims 1
- 230000008569 process Effects 0.000 claims 1
- 239000011347 resin Substances 0.000 claims 1
- 229920005989 resin Polymers 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 239000007790 solid phase Substances 0.000 claims 1
- 230000000087 stabilizing effect Effects 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 claims 1
- 208000030507 AIDS Diseases 0.000 abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5428—IL-10
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| WOPCT/DK96/00029 | 1996-01-18 | ||
| PCT/DK1996/000029 WO1997026278A1 (en) | 1996-01-18 | 1996-01-18 | Synthetic il-10 analogues |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2243275A1 true CA2243275A1 (en) | 1997-07-24 |
Family
ID=8155499
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002243275A Abandoned CA2243275A1 (en) | 1996-01-18 | 1997-01-16 | Synthetic il-10 analogues |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6936586B1 (OSRAM) |
| EP (1) | EP0879245A1 (OSRAM) |
| JP (1) | JP2000503652A (OSRAM) |
| KR (1) | KR19990077344A (OSRAM) |
| CN (1) | CN1226899A (OSRAM) |
| AP (1) | AP883A (OSRAM) |
| AR (1) | AR006517A1 (OSRAM) |
| AU (2) | AU4385696A (OSRAM) |
| BR (1) | BR9707036A (OSRAM) |
| CA (1) | CA2243275A1 (OSRAM) |
| PL (1) | PL327928A1 (OSRAM) |
| RU (1) | RU2194054C2 (OSRAM) |
| WO (2) | WO1997026278A1 (OSRAM) |
| ZA (1) | ZA9784B (OSRAM) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997026278A1 (en) * | 1996-01-18 | 1997-07-24 | Steeno Research Group A/S | Synthetic il-10 analogues |
| WO1998010792A1 (en) * | 1996-09-11 | 1998-03-19 | Prendergast Patrick T | Immune direction therapy |
| AU9449398A (en) * | 1997-10-10 | 1999-05-03 | Imperial College Innovations Ltd. | Use of csaidtm compounds for the management of uterine contractions |
| DE19851675A1 (de) * | 1998-11-10 | 2000-05-11 | Bayer Ag | Menschliche Interleukin-10 Mutantenproteine |
| US6685931B1 (en) | 1998-12-22 | 2004-02-03 | Schering Corporation | Treatment of hepatitis C virus infections with interleukin-10 |
| EP1265634A4 (en) * | 2000-03-14 | 2005-12-28 | Nat Jewish Med & Res Center | METHOD AND COMPOSITION FOR TREATING RESPIRATORY HYPERSENSIBILITY |
| US20070160576A1 (en) * | 2001-06-05 | 2007-07-12 | Genentech, Inc. | IL-17A/F heterologous polypeptides and therapeutic uses thereof |
| US6797722B2 (en) * | 2002-05-03 | 2004-09-28 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Use of 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole for the treatment of autoimmune diseases |
| RU2260598C2 (ru) * | 2003-10-29 | 2005-09-20 | Российский кардиологический научно-производственный комплекс Министерства здравоохранения РФ | Пептид, обладающий способностью ингибировать миграцию моноцитарных клеток, стимулированную белком мср-1 |
| GB0500643D0 (en) * | 2005-01-13 | 2005-02-23 | Renovo Ltd | Medicaments |
| PL2118123T3 (pl) | 2007-01-31 | 2016-06-30 | Dana Farber Cancer Inst Inc | Stabilizowane peptydy p53 i ich zastosowania |
| JP5631201B2 (ja) | 2007-03-28 | 2014-11-26 | プレジデント アンド フェローズ オブ ハーバード カレッジ | ステッチングされたポリペプチド |
| AU2014201269B2 (en) * | 2008-02-08 | 2016-09-15 | Aileron Therapeutics, Inc. | Therapeutic peptidomimetic macrocycles |
| CN104474529A (zh) | 2008-02-08 | 2015-04-01 | 爱勒让治疗公司 | 治疗性的拟肽大环化合物 |
| EP2768518A4 (en) | 2011-10-18 | 2015-05-27 | Aileron Therapeutics Inc | PEPTIDOMIMETIC MACROCYCLES |
| CA2864120A1 (en) | 2012-02-15 | 2013-08-22 | Aileron Therapeutics, Inc. | Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles |
| RU2642299C2 (ru) | 2012-02-15 | 2018-01-24 | Эйлерон Терапьютикс, Инк. | P53 пептидомиметические макроциклы |
| WO2014138429A2 (en) | 2013-03-06 | 2014-09-12 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and use thereof in regulating hif1alpha |
| EP3197478A4 (en) | 2014-09-24 | 2018-05-30 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
| JP2018516844A (ja) | 2015-03-20 | 2018-06-28 | エルロン・セラピューティクス・インコーポレイテッドＡｉｌｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | ペプチド模倣大環状分子およびその使用 |
| EP3347372A4 (en) | 2015-09-10 | 2019-09-04 | Aileron Therapeutics, Inc. | PEPTIDOMIMETIC MACROCYCLES AS MODULATORS OF MCL-1 |
| EP3551034A1 (en) | 2016-12-07 | 2019-10-16 | Progenity, Inc. | Gastrointestinal tract detection methods, devices and systems |
| CA3054156A1 (en) | 2017-03-30 | 2018-10-04 | Progenity Inc. | Treatment of a disease of the gastrointestinal tract with il-10 or an il-10 agonist |
| WO2020106757A1 (en) | 2018-11-19 | 2020-05-28 | Progenity, Inc. | Ingestible device for delivery of therapeutic agent to the gastrointestinal tract |
| BR102019007044A2 (pt) * | 2019-04-05 | 2021-12-28 | Universidade Federal de Uberlândia | Peptídeos sintéticos com afinidade ao receptor de interleucina-10, composição farmacêutica e uso dos mesmos como imunomuduladores no tratamento de doenças autoimunes, inflamatórias ou alérgicas |
| CN121197633A (zh) | 2019-12-13 | 2025-12-26 | 比特比德科有限责任公司 | 用于将治疗剂递送至胃肠道的可摄取装置 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
| US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| IL94878A (en) * | 1989-06-28 | 2003-01-12 | Schering Corp | Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same |
| US5624823A (en) * | 1991-11-22 | 1997-04-29 | The General Hospital Corporation | DNA encoding procine interleukin-10 |
| CA2131524A1 (en) | 1992-03-04 | 1993-09-16 | Maria-Grazia Roncarolo | Use of interleukin-10 to suppress graft-vs.-host disease |
| RU2051922C1 (ru) * | 1992-06-19 | 1996-01-10 | Людмила Яковлевна Соловьева | СПОСОБ ВЫДЕЛЕНИЯ РЕКОМБИНАНТНОГО ИНТЕРЛЕЙКИНА - 1β ИЗ БИОМАССЫ МИКРООРГАНИЗМОВ |
| CA2085291A1 (en) | 1992-07-30 | 1994-01-31 | Martin L. Breitman | Novel receptor tyrosine kinase |
| US5328989A (en) * | 1993-03-05 | 1994-07-12 | Schering-Plough | Purification of human interleukin-10 from a cell culture medium |
| US5446128A (en) | 1993-06-18 | 1995-08-29 | The Board Of Trustees Of The University Of Illinois | Alpha-helix mimetics and methods relating thereto |
| IL110413A0 (en) | 1993-07-26 | 1994-10-21 | Schering Corp | Agonists and antagonists of human interleukin-10 |
| US6159937A (en) * | 1994-07-05 | 2000-12-12 | Steeno Research Group A/S | Immunomodulators |
| US5654276A (en) * | 1995-06-07 | 1997-08-05 | Affymax Technologies N.V. | Peptides and compounds that bind to the IL-5 receptor |
| WO1997026278A1 (en) * | 1996-01-18 | 1997-07-24 | Steeno Research Group A/S | Synthetic il-10 analogues |
-
1996
- 1996-01-18 WO PCT/DK1996/000029 patent/WO1997026278A1/en not_active Ceased
- 1996-01-18 AU AU43856/96A patent/AU4385696A/en not_active Abandoned
-
1997
- 1997-01-06 ZA ZA9700084A patent/ZA9784B/xx unknown
- 1997-01-16 KR KR1019980705491A patent/KR19990077344A/ko not_active Ceased
- 1997-01-16 BR BR9707036-0A patent/BR9707036A/pt not_active Application Discontinuation
- 1997-01-16 CN CN97193092A patent/CN1226899A/zh active Pending
- 1997-01-16 AU AU13011/97A patent/AU718476B2/en not_active Ceased
- 1997-01-16 CA CA002243275A patent/CA2243275A1/en not_active Abandoned
- 1997-01-16 EP EP97900549A patent/EP0879245A1/en not_active Withdrawn
- 1997-01-16 US US09/101,825 patent/US6936586B1/en not_active Expired - Fee Related
- 1997-01-16 JP JP9525609A patent/JP2000503652A/ja not_active Ceased
- 1997-01-16 WO PCT/DK1997/000021 patent/WO1997026279A1/en not_active Ceased
- 1997-01-16 RU RU98115293/04A patent/RU2194054C2/ru not_active IP Right Cessation
- 1997-01-16 PL PL97327928A patent/PL327928A1/xx unknown
- 1997-01-16 AP APAP/P/1998/001295A patent/AP883A/en active
- 1997-01-17 AR ARP970100194A patent/AR006517A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0879245A1 (en) | 1998-11-25 |
| ZA9784B (en) | 1997-07-17 |
| JP2000503652A (ja) | 2000-03-28 |
| KR19990077344A (ko) | 1999-10-25 |
| AU718476B2 (en) | 2000-04-13 |
| PL327928A1 (en) | 1999-01-04 |
| AU4385696A (en) | 1997-08-11 |
| AP883A (en) | 2000-10-25 |
| WO1997026278A1 (en) | 1997-07-24 |
| BR9707036A (pt) | 1999-08-31 |
| RU2194054C2 (ru) | 2002-12-10 |
| WO1997026279A1 (en) | 1997-07-24 |
| AP9801295A0 (en) | 1998-09-30 |
| AU1301197A (en) | 1997-08-11 |
| AR006517A1 (es) | 1999-09-08 |
| US6936586B1 (en) | 2005-08-30 |
| CN1226899A (zh) | 1999-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU718476B2 (en) | Synthetic IL-10 analogues | |
| US6168791B1 (en) | Antibodies that bind immunomodulators | |
| RU98115293A (ru) | Синтетические аналоги il-10 | |
| CA2082804A1 (en) | Methods and compositions for treatment of angiogenic diseases | |
| EP0593585A1 (en) | Peptide which abrogates tnf and/or lps toxicity | |
| WO1998054210A1 (en) | Peptide compositions for tumor inhibition | |
| JP2012509312A (ja) | 腫瘍壊死因子α阻害ペプチドおよびその使用方法 | |
| Schmidt et al. | Interleukin-1 | |
| RU2503684C2 (ru) | Иммуномодулирующие олигопептиды | |
| MXPA98005648A (en) | Synthetic il-10 analogues | |
| HK1012416B (en) | Immunomodulators | |
| WO1997043308A1 (en) | Lipophile derivatives of muramylpeptides for treatment of retroviral infection and induction of chemokines | |
| Boger et al. | Immunomodulatory approaches to the treatment of inflammation | |
| Dy | Interleukin 3 (IL-3) and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Production by Normal and Tumor Cells: Effect on Hematopoietic Cell Histamine Synthesis | |
| AU673332C (en) | Peptide which abrogates TNF and/or LPS toxicity | |
| US6010876A (en) | Clavanins | |
| JPH06506918A (ja) | インターロイキン−１の産生を促進しそして年令−関連性免疫応答を調整するペプチドｍｂ−４ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |